Cargando…

Hemovigilance Program–India

A centralized hemovigilance program to assure patient safety and to promote public health has been launched for the first time in India on Dec 10, 2012 in 60 medical colleges in the first phase along with a well-structured program for monitoring adverse reactions associated with blood transfusion an...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisht, Akanksha, Singh, Surinder, Marwaha, Neelam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613669/
https://www.ncbi.nlm.nih.gov/pubmed/23559771
http://dx.doi.org/10.4103/0973-6247.106744
_version_ 1782264760847302656
author Bisht, Akanksha
Singh, Surinder
Marwaha, Neelam
author_facet Bisht, Akanksha
Singh, Surinder
Marwaha, Neelam
author_sort Bisht, Akanksha
collection PubMed
description A centralized hemovigilance program to assure patient safety and to promote public health has been launched for the first time in India on Dec 10, 2012 in 60 medical colleges in the first phase along with a well-structured program for monitoring adverse reactions associated with blood transfusion and blood product administration. National Institute of Biologicals (NIB) will be the National Coordinating Centre for Hemovigilance. This program will be implemented under overall ambit of Pharmacovigilance Program of India (PvPI), which is being coordinated by Indian Pharmacopoeia Commission (IPC). All medical colleges of the country will be enrolled in this program by the year 2016 in order to have a National Centre of Excellence for Hemovigilance at NIB, which will act as a global knowledge platform.
format Online
Article
Text
id pubmed-3613669
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-36136692013-04-04 Hemovigilance Program–India Bisht, Akanksha Singh, Surinder Marwaha, Neelam Asian J Transfus Sci Brief Communication A centralized hemovigilance program to assure patient safety and to promote public health has been launched for the first time in India on Dec 10, 2012 in 60 medical colleges in the first phase along with a well-structured program for monitoring adverse reactions associated with blood transfusion and blood product administration. National Institute of Biologicals (NIB) will be the National Coordinating Centre for Hemovigilance. This program will be implemented under overall ambit of Pharmacovigilance Program of India (PvPI), which is being coordinated by Indian Pharmacopoeia Commission (IPC). All medical colleges of the country will be enrolled in this program by the year 2016 in order to have a National Centre of Excellence for Hemovigilance at NIB, which will act as a global knowledge platform. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3613669/ /pubmed/23559771 http://dx.doi.org/10.4103/0973-6247.106744 Text en Copyright: © Asian Journal of Transfusion Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communication
Bisht, Akanksha
Singh, Surinder
Marwaha, Neelam
Hemovigilance Program–India
title Hemovigilance Program–India
title_full Hemovigilance Program–India
title_fullStr Hemovigilance Program–India
title_full_unstemmed Hemovigilance Program–India
title_short Hemovigilance Program–India
title_sort hemovigilance program–india
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613669/
https://www.ncbi.nlm.nih.gov/pubmed/23559771
http://dx.doi.org/10.4103/0973-6247.106744
work_keys_str_mv AT bishtakanksha hemovigilanceprogramindia
AT singhsurinder hemovigilanceprogramindia
AT marwahaneelam hemovigilanceprogramindia